#monoamine

Polyetheramine is a type of polyamine that is used in a variety of applications, such as coatings, adhesives, sealants, and elastomers. It is a colorless, water-soluble substance that can be used as a curing agent or as a building block for other types of polymers. Polyetheramine is popular due to its low cost, low toxicity, and resistance to degradation. The demand for Polyetheramine has been increasing in recent years due to its wide range of applications in various industries. It is used in industrial coatings, adhesives, elastomers, and sealants, as well as in the production of rubber and plastics. It is also used as a fuel additive, in the formulation of detergents, and as a corrosion inhibitor. Polyetheramine is also used in the automotive industry as a lubricant, antifreeze, and coolant.

 The global polyetheramine market was valued at USD 625.8 Million in 2016 and is projected to reach USD 1,074.0 Million by 2022, at a CAGR of 9.3% from 2017 to 2022.  The key players, such as Huntsman Corporation (U.S.) and BASF SE (Germany), have adopted these strategies to develop their businesses, globally. Increasing demand for advanced coatings, improving living standards of populations, and the use of composites in wind energy blades have led to a rise in the demand for polyetheramine.

Huntsman Corporation is a major player in the polyetheramine market. The company’s wide range of business segments provides an added advantage to the company’s profit margin, which enables it to compensate losses from low performing business segments and enables investments in strategic expansions and R&D activities. The performance products business segment includes polyetheramine products. The company earned around 24% of its revenue from performance products business segment in 2015 and is planning to invest further in this segment to enhance its sales globally. The company follows growth strategies such as capacity expansions and investing in R&D activities to meet the growing demand, improve product cost competitiveness, and enhance its product portfolio for new applications to cater to the market. In May 2015, Huntsman Corporation expanded its production capacity of Conroe chemical plant, which has polyetheramine manufacturing facility. 

BASF SE is another major player in the polyetheramine market. Europe accounted for 44% of the overall company revenue in 2015. The chemical business segment of the company manufactures polyetheramine for various applications and end users. This business segment earned around 22% of its revenue in 2015. The company’s business strategy mainly revolves around its targets to increase global reach, enhance revenue, and launch innovative solutions through its products. As a part of its growth strategy, the company plans to establish new production facilities and expand its existing plant capacities which could enable the company to take advantage of the opportunities in the high growth polyetheramine market. In April 2016, BASF SE inaugurated a new plant to produce specialty amines in the Nanjing Chemical Industry Park in Nanjing, China, as part of a move to open first specialty amines plant in Asia-Pacific. This expansion is expected to meet the growing market demands of polyetheramine in personal care, construction, wind energy, and coatings sectors. 

That’s right. Small molecule transmitters. Yes, there are large molecule transmitters but those are (Neuro)peptides.

There are four main types of small molecule neurotransmitters: Amino acides, monoamines, soluble gases and acetylcholine.

Monoamines have two categories: catecholamines and indoleamines

Catecholamines are your epinephrine and norepniphrine, and dopamines.

(Nor)Epinephrine is the exact same thing as (nor)andrenalin. Apparently some asshole decided it would be a good idea to patent andrenalin which is why we all call it epinephrine now. But yeah, same fuckin thing. And there really isn't much of a difference between norepinephrine and epinephrine either. Scientist who found them were pretty much like: yeah, it's kind of like epinephrine, let's call it not-exactly-epinephrine. Hense: norepinephrine.

Dopamine is an NT that synapses around the substantia nigra and basal ganglia and helps initiation of voluntary movements. Defective dopamine transmission causes various problems like Parkinson's or schizophrenia. It's also a huge reward center in your brain, so it plays a huge role in addiction.

If there’s too much norepinephrin floating around in the cell then an enzyme (Monoamine oxidase [MAO]) comes by to break it down. When you hear a commercial for anti-depressants, you'll hear them talk about MAOIs, which are monoamine oxidase inhibitors. It inhibits MAOs from destroying your nice catecholamines and it'll make you happier.